<DOC>
	<DOCNO>NCT00599443</DOCNO>
	<brief_summary>A control , double blind study determine safety reactogenicity healthy adult single dose trivalent cell-derived influenza vaccine administer intramuscular injection .</brief_summary>
	<brief_title>Safety Tolerability Cell-Derived Influenza Vaccine Healthy Adults Aged ≥18 Years ≤ 49 Years</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy female male subject age ≧18 ≦49 year Willing able give inform consent Influenza vaccination laboratory confirm influenza infection within six month inform consent , presence significant medical condition , serious adverse reaction previous ( influenza ) vaccination , underlie medical condition annual influenza vaccine recommend Advisory Committee Immunization Practices ( ACIP ) , chronic disease require longterm immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Cell-derived subunit influenza vaccine</keyword>
	<keyword>Safety</keyword>
	<keyword>Reactogenicity</keyword>
</DOC>